Biliary Tract Cancers Version 1.2025
Bladder Cancer Version 1.2025
Bone Cancer Version 2.2025
Breast Cancer Version 3.2025
Central Nervous System Cancers Version 5.2024
Cervical Cancer Version 4.2025
Esophageal and Esophagogastric Junction Cancers Version 2.2025
Gastric Cancer Version 1.2025
Hepatocellular Carcinoma Version 1.2025
Neuroendocrine and Adrenal Tumors Version 5.2024
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Version 1.2025
Pediatric Acute Lymphoblastic Leukemia Version 3.2025
Soft Tissue Sarcoma Version 5.2024
Systemic Light Chain Amyloidosis Version 2.2025
Testicular Cancer Version 2.2025
Uterine Neoplasms Version 3.2025
Vaginal Cancer Version 5.2025
Wilms Tumor (Nephroblastoma) Version 1.2025
NCCN Guidelines with Evidence Blocks - Bladder Cancer Version 7.2024
NCCN Guidelines with Evidence Blocks - Bone Cancer Version 2.2025
NCCN Guidelines with Evidence Blocks - Neuroendocrine and Adrenal Tumors Version 5.2024
NCCN Guidelines with Evidence Blocks - Systemic Light Chain Amyloidosis Version 2.2025
NCCN Guidelines with Evidence Blocks - Uterine Neoplasms Version 3.2025
NCCN Guidelines with Evidence Blocks - Vaginal Cancer Version 5.2025
Breast Cancer Screening and Diagnosis Version 1.2025
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Version 3.2025
Prostate Cancer Early Detection Version 1.2025
Adult Cancer Pain Version 1.2025
Cancer-Associated Venous Thromboembolic Disease Version 1.2025
Hematopoietic Cell Transplantation Version 1.2025